Martin Göttlicher

Title: Martin Göttlicher: Innovator in Tumor Treatment

Introduction

Martin Göttlicher is a prominent inventor based in Stutensee, Germany. He has made significant contributions to the field of medical science, particularly in the development of treatments for tumor diseases and immunosuppression. His innovative approach has the potential to impact the lives of many patients suffering from these conditions.

Latest Patents

Martin Göttlicher holds a patent for a method for producing agents for treating tumor diseases and for immunosuppression. The invention relates to a process for preparing agents that are suitable for treating tumor diseases or for immunosuppression. This process involves treating target cells with chemical compounds that bind to the Ah receptor of the target cells. The binding of these chemical compounds is determined by measuring the expression of a detector gene that is relevant for the effects of the compounds. The compounds identified through this method are then used to prepare the agents.

Career Highlights

Martin Göttlicher is associated with Forschungszentrum Karlsruhe GmbH, where he has been involved in groundbreaking research. His work has led to advancements in the understanding and treatment of tumor diseases, showcasing his dedication to improving medical outcomes.

Collaborations

He has collaborated with notable colleagues, including Siva Kumar Kolluri and Carsten Weiss, to further enhance the research and development of innovative treatments.

Conclusion

Martin Göttlicher's contributions to the field of tumor treatment exemplify the importance of innovation in medical science. His patented method represents a significant step forward in the fight against tumor diseases and immunosuppression.